Postmenopausal Hormone Therapy and Atherosclerosis--Time Is of the Essence.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Menopausal hormone therapy and women's health: An umbrella review.PLoS medicine · 2021
   Pooled it
2. Targeting estrogen receptor signaling for treating heart failure.Heart failure reviews · 2024
   Review
3. Sex differences and related estrogenic effects in heart failure with preserved ejection fraction.Heart failure reviews · 2023
   Review
4. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.PLoS medicine · 2017
   Observational
5. A theory of eu-estrogenemia: a unifying concept.Menopause (New York, N.Y.) · 2017
   Review
6. Cancer Prevention: Lessons Learned and Future Directions.Trends in cancer · 2016
   Review
7. Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends.Chemical research in toxicology · 2016
   Review

Corrections and comments

• Comment on
  Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.2016

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as